<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.0 20040830//EN" "http://dtd.nlm.nih.gov/publishing/2.0/journalpublishing.dtd">
<?covid-19-tdm?>
<article article-type="article-commentary" dtd-version="2.0" xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">JMIRxMed</journal-id>
      <journal-id journal-id-type="nlm-ta">JMIRx Med</journal-id>
      <journal-title>JMIRx Med</journal-title>
      <issn pub-type="epub">2563-6316</issn>
      <publisher>
        <publisher-name>JMIR Publications</publisher-name>
        <publisher-loc>Toronto, Canada</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">v2i4e34083</article-id>
      <article-id pub-id-type="pmid"/>
      <article-id pub-id-type="doi">10.2196/34083</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Peer-Review Report</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Peer-Review Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Peer Review of “Machine Learning–Based Prediction of COVID-19 Mortality With Limited Attributes to Expedite Patient Prognosis and Triage: Retrospective Observational Study”</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="editor">
          <name>
            <surname>Meinert</surname>
            <given-names>Edward</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib id="contrib1" contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Moquillaza Alcántara</surname>
            <given-names>Victor Hugo</given-names>
          </name>
          <degrees>MSc</degrees>
          <xref rid="aff1" ref-type="aff">1</xref>
          <ext-link ext-link-type="orcid">https://orcid.org/0000-0002-0362-907X</ext-link>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <institution>Data Management Area</institution>
        <institution>Asociación Via Libre</institution>
        <addr-line>Lima</addr-line>
        <country>Peru</country>
      </aff>
      <pub-date pub-type="collection">
        <season>Oct-Dec</season>
        <year>2021</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>15</day>
        <month>10</month>
        <year>2021</year>
      </pub-date>
      <volume>2</volume>
      <issue>4</issue>
      <elocation-id>e34083</elocation-id>
      <history>
        <date date-type="received">
          <day>5</day>
          <month>10</month>
          <year>2021</year>
        </date>
        <date date-type="accepted">
          <day>5</day>
          <month>10</month>
          <year>2021</year>
        </date>
      </history>
      <copyright-statement>©Victor Hugo Moquillaza Alcántara. Originally published in JMIRx Med (https://med.jmirx.org), 15.10.2021.</copyright-statement>
      <copyright-year>2021</copyright-year>
      <license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIRx Med, is properly cited. The complete bibliographic information, a link to the original publication on https://med.jmirx.org/, as well as this copyright and license information must be included.</p>
      </license>
      <self-uri xlink:href="https://med.jmirx.org/2021/4/e34083" xlink:type="simple"/>
      <related-article related-article-type="companion" id="preprint21253984" ext-link-type="doi" xlink:href="https://doi.org/10.1101/2021.03.21.21253984" vol="1" page="21253984" xlink:title="Preprint (MedRxiv):" xlink:type="simple">https://www.medrxiv.org/content/10.1101/2021.03.21.21253984v2</related-article>
      <related-article related-article-type="companion" id="preprint29392" ext-link-type="doi" xlink:href="https://doi.org/10.2196/preprints.29392" vol="2" page="e29392" xlink:title="Preprint (JMIR Preprints):" xlink:type="simple">https://preprints.jmir.org/preprint/29392</related-article>
      <related-article related-article-type="companion" id="v2i4e34081" ext-link-type="doi" xlink:href="10.2196/34081" vol="2" page="e34081" xlink:title="Author's Response to Peer-Review Reports:" xlink:type="simple">https://med.jmirx.org/2021/4/e34081/</related-article>
      <related-article related-article-type="companion" id="v2i4e29392" ext-link-type="doi" xlink:href="10.2196/29392" vol="2" page="e29392" xlink:title="Published Article:" xlink:type="simple">https://med.jmirx.org/2021/4/e29392/</related-article>
      <kwd-group>
        <kwd>COVID-19</kwd>
        <kwd>coronavirus</kwd>
        <kwd>medical informatics</kwd>
        <kwd>machine learning</kwd>
        <kwd>artificial intelligence</kwd>
        <kwd>dimensionality reduction</kwd>
        <kwd>automation</kwd>
        <kwd>model development</kwd>
        <kwd>prediction</kwd>
        <kwd>hospital</kwd>
        <kwd>resource management</kwd>
        <kwd>mortality</kwd>
        <kwd>prognosis</kwd>
        <kwd>triage</kwd>
        <kwd>comorbidities</kwd>
        <kwd>public data</kwd>
        <kwd>epidemiology</kwd>
        <kwd>pre-existing conditions</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>
      <italic>This is a peer-review report submitted for the paper “Machine Learning–Based Prediction of COVID-19 Mortality With Limited Attributes to Expedite Patient Prognosis and Triage: Retrospective Observational Study.”</italic>
    </p>
    <sec>
      <title>Round 1 Review</title>
      <sec>
        <title>General Comments</title>
        <p>This paper [<xref ref-type="bibr" rid="ref1">1</xref>] shows useful information that would allow better health management in countries with a high incidence of COVID-19 cases. The rationale for the study is clear, but there is little scientific literature to support the information presented.</p>
      </sec>
      <sec>
        <title>Specific Comments</title>
        <sec>
          <title>Major Comments</title>
          <p>1. The introduction of the paper presents only 4 bibliographic references, which is scarce to defend the problem and justification of a study. In the summary, he mentioned at the beginning that human resources in hospitals are scarce, which is an important reality that has not been addressed in the introduction of the paper. I suggest starting by evaluating the problem of hospital saturation, with epidemiological indicators from various studies that can support this information (this will notably increase the number of references); then, justify the study with the potential benefits of using these types of tools.</p>
          <p>2. During the discussion, technical aspects of the statistical models used are evaluated; however, I suggest that a comparison or appreciation can be provided regarding the utility and impact that these results would show in public health.</p>
        </sec>
        <sec>
          <title>Minor Comments</title>
          <p>3. In the Abstract, it is suggested that the general objective of the study be reported. Remember that the summary seeks to capture the reader’s attention and not saturate them with details.</p>
          <p>4. In the first line of the introduction of the study, it says “... development of the COVID-19”; it should say “... development of the Coronavirus Disease (COVID-19)”. Remember that the first time an acronym is mentioned, its full name must be written.</p>
          <p>5. According to the International Committee of Biomedical Journal Editors, the table description should be at the top of the table. In Tables 1, 2, and 3, the description is below.</p>
          <p>6. In order that the tables and figures do not leave doubts to the readers, I suggest that in Table 2, there should be a footnote where it is specified what the author refers to with “AUC.”</p>
        </sec>
      </sec>
    </sec>
  </body>
  <back>
    <app-group/>
    <fn-group>
      <fn fn-type="conflict">
        <p>None declared.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="ref1">
        <label>1</label>
        <nlm-citation citation-type="journal">
          <person-group person-group-type="author">
            <name name-style="western">
              <surname>Doyle</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Machine learning–based prediction of COVID-19 mortality with limited attributes to expedite patient prognosis and triage: retrospective observational study</article-title>
          <source>JMIRx Med</source>
          <year>2021</year>
          <volume>2</volume>
          <issue>4</issue>
          <fpage>e29392</fpage>
          <comment>
            <ext-link ext-link-type="uri" xlink:type="simple" xlink:href="https://med.jmirx.org/2021/4/e29392/"/>
          </comment>
          <pub-id pub-id-type="doi">10.2196/29392</pub-id>
        </nlm-citation>
      </ref>
    </ref-list>
  </back>
</article>
